Vaxart, Inc. (VXRT) Shareholder/Analyst Call Transcript

Vaxart, Inc. (VXRT) discussed its recent developments in a shareholder/analyst call, highlighting advances in its oral vaccine technology. The company reported on its ongoing trials and partnerships aiming to accelerate product development. There was a positive market reception as analysts expressed optimism about potential FDA approvals. Shareholder engagement also increased, indicating renewed investor interest. Overall, the outlook for Vaxart appears bullish as they work toward commercializing their pipeline.